Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Journal of Gastroenterology|December 7, 2010
Predictive value of tumor markers for hepatocarcinogenesis in patients with hepatitis C virusTakashi Kumada, Hidenori Toyoda, Seiki Kiriyama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 19, 2016
Post-treatment levels of α-fetoprotein predict long-term hepatocellular carcinoma development after sustained virological response in patients with hepatitis CToshifumi Tada, Takashi Kumada, Hidenori Toyoda, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 4, 2008
Eight-week regimen of antiviral combination therapy with peginterferon and ribavirin for patients with chronic hepatitis C with hepatitis C virus genotype 2 and a rapid virological responseHidenori Toyoda, Takashi Kumada, Seiki Kiriyama, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 25, 2006
Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinomaHidenori Toyoda, Takashi Kumada, Seiki Kiriyama, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 8, 2006
Impact of surveillance on survival of patients with initial hepatocellular carcinoma: a study from JapanHidenori Toyoda, Takashi Kumada, Seiki Kiriyama, et al.
The American Journal of Gastroenterology|August 10, 2005
Comparison of the usefulness of three staging systems for hepatocellular carcinoma (CLIP, BCLC, and JIS) in JapanHidenori Toyoda, Takashi Kumada, Seiki Kiriyama, et al.
Endoscopy International Open|January 22, 2016
Long- and short-term outcomes of ERCP for bile duct stones in patients over 80 years old compared to younger patients: a propensity score analysisAkira Kanamori, Seiki Kiriyama, Makoto Tanikawa, et al.
Hepato-Gastroenterology|October 26, 2002
Prospective study of a high-intensity interferon-alpha regimen for chronic hepatitis C virus genotype 1b infectionHidenori Toyoda, Takashi Kumada, Satoshi Nakano, et al.
Pageof 5